KMT5A
MOLECULAR TARGETlysine methyltransferase 5A
KMT5A (lysine methyltransferase 5A) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting KMT5A
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Cyproheptadine | 0.69 | 1 |
About KMT5A as a Drug Target
KMT5A (lysine methyltransferase 5A) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented KMT5A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
KMT5A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.